Levels of plasma des-γ -carboxy protein C and prothrombin in patients with liver diseases

Table 1 The levels of PC:C and PC:Ag in patients with liver diseases (mean ± SD)

	n	PC:C (%)	PC:Ag (μg/mL)
Control	20	104.65 ± 23.0	5.31 ± 1.63
Hepatocellular carcinoma	18	62.50 ± 24.89a	2.28 ± 1.15b
Liver cirrhosis	20	56.75 ± 20.14a	2.43 ± 0.79b
Acute viral hepatitis	15	93.76 ± 30.49	2.98 ± 0.91b

^aP < 0.05,

^bP < 0.01 vs control group.

Table 2 The levels of DCPC in patients with liver diseases (mean ± SD)

	n	Total PC:Ag (μg/mL)	DCPC:Ag (μg/mL)	DCPC:Ag Total PC:Ag
Control	15	5.23 ± 1.95	0.69 ± 0.29	13.19%
Hepatocellular carcinoma	15	2.33 ± 1.21	1.18 ± 0.63b	50.64%b
Acute viral hepatitis	15	2.98 ± 0.91	0.45 ± 0.21	15.10%

^bP < 0.01 vs control and acute viral hepatitis groups.

Table 3 The levels of prothrombin in patients with liver diseases (mean ± SD)

	n	Total prothrombin (%)	Unabsorbed prothrombin (%)
Control	20	101.99 ± 12.29	0.30 ± 0.18
Hepatocellular carcinoma	18	220.61 ± 67.95b	2.87 ± 0.89b
Liver cirrhosis	10	85.33 ± 6.99a	0.95 ± 0.45a
Acute viral hepatitis	15	99.05 ± 14.97	1.09 ± 0.36a

^aP < 0.05,

^bP < 0.01 vs control groups